Dosierung von Neuroleptika

作者: B. Woggon

DOI: 10.1007/978-3-642-83188-1_8

关键词:

摘要: Seit der Entdeckung des ersten Neuroleptikums sind 34 Jahre vergangen. Inzwischen ist gesichert, das Neuroleptika antipsychotisch wirken und sie den Verlauf Schizophrenie durch ihre ruckfallverhutende Wirkung beeinflussen konnen.

参考文章(13)
Dissimilar dosing with high-potency and low-potency neuroleptics. American Journal of Psychiatry. ,vol. 141, pp. 748- 752 ,(1984) , 10.1176/AJP.141.6.748
E. Lehmann, H. Quadbeck, J. Tegeler, M. Fararuni, K. Heinrich, [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)]. Pharmacopsychiatry. ,vol. 13, pp. 117- 129 ,(1980) , 10.1055/S-2007-1019621
Göran Sedvall, Lars Farde, Anders Persson, Frits-Axel Wiesel, Imaging of Neurotransmitter Receptors in the Living Human Brain Archives of General Psychiatry. ,vol. 43, pp. 995- 1005 ,(1986) , 10.1001/ARCHPSYC.1986.01800100089012
N. Nedopil, E. Eben, H. Klein, R. Krüger, E. Rüther, M. Schmauss, High-dosage neuroleptic therapy for acute schizophrenic patients--two double-blind studies with benperidol. Pharmacopsychiatry. ,vol. 18, pp. 63- 66 ,(1985) , 10.1055/S-2007-1017313
Mervin L. Clark, Chlorpromazine in Chronic Schizophrenia Archives of General Psychiatry. ,vol. 27, pp. 479- 483 ,(1972) , 10.1001/ARCHPSYC.1972.01750280047009
Ross J. Baldessarini, John M. Davis, What Is the Best Maintenance Dose of Neuroleptics in Schizophrenia Psychiatry Research-neuroimaging. ,vol. 3, pp. 115- 122 ,(1980) , 10.1016/0165-1781(80)90028-1
Ranan Rim�n, Ilya Averbuch, Pablo Rozick, L. Fijman-Danilovich, Thomas Kara, Haim Dasberg, Richard P. Ebstein, Robert H. Belmaker, Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients. Psychopharmacology. ,vol. 73, pp. 197- 199 ,(1981) , 10.1007/BF00429218
Nathan S. Kline, Chlorpromazine in Chronic Schizophrenia British Journal of Psychiatry. ,vol. 114, pp. 243- 243 ,(1968) , 10.1192/BJP.114.507.243-A
J. M. Davis, C. B. Schaffer, G. A. Killian, C. Kinard, C. Chan, Important Issues in the Drug Treatment of Schizophrenia Schizophrenia Bulletin. ,vol. 6, pp. 70- 87 ,(1980) , 10.1093/SCHBUL/6.1.70